Nota técnica
Reactividad cruzada de preparados de insulina recombinante con 2 inmunoanálisis comerciales para determinación de insulina en sangre
Cross-reactivity of recombinant insulin preparations with two commercial insulin inmunoassays
Leído
4361
Vecesse ha leído el artículo
923
Total PDF
3438
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 12 | 9 | 4 | 13 |
| 2025 11 | 76 | 33 | 109 |
| 2025 10 | 66 | 9 | 75 |
| 2025 9 | 62 | 12 | 74 |
| 2025 8 | 57 | 15 | 72 |
| 2025 7 | 41 | 13 | 54 |
| 2025 6 | 54 | 4 | 58 |
| 2025 5 | 64 | 4 | 68 |
| 2025 4 | 54 | 1 | 55 |
| 2025 3 | 81 | 6 | 87 |
| 2025 2 | 48 | 5 | 53 |
| 2025 1 | 44 | 4 | 48 |
| 2024 12 | 109 | 4 | 113 |
| 2024 11 | 37 | 13 | 50 |
| 2024 10 | 36 | 3 | 39 |
| 2024 9 | 67 | 5 | 72 |
| 2024 8 | 54 | 2 | 56 |
| 2024 7 | 36 | 2 | 38 |
| 2024 6 | 35 | 4 | 39 |
| 2024 5 | 24 | 2 | 26 |
| 2024 4 | 31 | 2 | 33 |
| 2024 3 | 39 | 0 | 39 |
| 2024 2 | 51 | 0 | 51 |
| 2024 1 | 48 | 1 | 49 |
| 2023 12 | 33 | 0 | 33 |
| 2023 11 | 34 | 0 | 34 |
| 2023 10 | 23 | 0 | 23 |
| 2023 9 | 23 | 0 | 23 |
| 2023 8 | 10 | 0 | 10 |
| 2023 7 | 12 | 0 | 12 |
| 2023 6 | 28 | 0 | 28 |
| 2023 5 | 58 | 2 | 60 |
| 2023 4 | 11 | 0 | 11 |
| 2023 3 | 13 | 0 | 13 |
| 2023 2 | 8 | 0 | 8 |
| 2022 1 | 5 | 2 | 7 |
| 2022 12 | 4 | 2 | 6 |
| 2022 11 | 5 | 0 | 5 |
| 2022 10 | 3 | 0 | 3 |
| 2022 9 | 6 | 0 | 6 |
| 2022 8 | 4 | 0 | 4 |
| 2022 7 | 4 | 0 | 4 |
| 2022 6 | 17 | 13 | 30 |
| 2022 5 | 42 | 6 | 48 |
| 2022 4 | 62 | 18 | 80 |
| 2022 3 | 60 | 24 | 84 |
| 2022 2 | 43 | 6 | 49 |
| 2021 1 | 31 | 6 | 37 |
| 2021 12 | 41 | 16 | 57 |
| 2021 11 | 39 | 6 | 45 |
| 2021 10 | 50 | 20 | 70 |
| 2021 9 | 29 | 5 | 34 |
| 2021 8 | 23 | 9 | 32 |
| 2021 7 | 25 | 7 | 32 |
| 2021 6 | 8 | 3 | 11 |
| 2021 5 | 24 | 7 | 31 |
| 2021 4 | 67 | 25 | 92 |
| 2021 3 | 28 | 7 | 35 |
| 2021 2 | 47 | 6 | 53 |
| 2020 1 | 33 | 12 | 45 |
| 2020 12 | 44 | 16 | 60 |
| 2020 11 | 18 | 4 | 22 |
| 2020 10 | 14 | 18 | 32 |
| 2020 9 | 19 | 10 | 29 |
| 2020 8 | 24 | 7 | 31 |
| 2020 7 | 25 | 18 | 43 |
| 2020 6 | 28 | 6 | 34 |
| 2020 5 | 25 | 13 | 38 |
| 2020 4 | 13 | 6 | 19 |
| 2020 3 | 4 | 1 | 5 |
| 2020 1 | 0 | 2 | 2 |
| 2019 12 | 1 | 0 | 1 |
| 2018 5 | 1 | 0 | 1 |
| 2018 2 | 7 | 4 | 11 |
| 2018 1 | 8 | 2 | 10 |
| 2017 12 | 9 | 0 | 9 |
| 2017 11 | 9 | 10 | 19 |
| 2017 10 | 13 | 6 | 19 |
| 2017 9 | 21 | 20 | 41 |
| 2017 8 | 16 | 4 | 20 |
| 2017 7 | 20 | 4 | 24 |
| 2017 6 | 18 | 9 | 27 |
| 2017 5 | 17 | 6 | 23 |
| 2017 4 | 24 | 9 | 33 |
| 2017 3 | 11 | 31 | 42 |
| 2017 2 | 24 | 4 | 28 |
| 2016 1 | 14 | 7 | 21 |
| 2016 12 | 30 | 15 | 45 |
| 2016 11 | 35 | 14 | 49 |
| 2016 10 | 42 | 19 | 61 |
| 2016 9 | 36 | 5 | 41 |
| 2016 8 | 31 | 10 | 41 |
| 2016 7 | 30 | 5 | 35 |
| 2016 6 | 15 | 15 | 30 |
| 2016 5 | 20 | 13 | 33 |
| 2016 4 | 9 | 18 | 27 |
| 2016 3 | 19 | 26 | 45 |
| 2016 2 | 13 | 21 | 34 |
| 2015 1 | 19 | 22 | 41 |
| 2015 12 | 16 | 26 | 42 |
| 2015 11 | 14 | 22 | 36 |
| 2015 10 | 34 | 21 | 55 |
| 2015 9 | 23 | 12 | 35 |
| 2015 8 | 18 | 14 | 32 |
| 2015 7 | 6 | 14 | 20 |
| 2015 6 | 11 | 14 | 25 |
| 2015 5 | 14 | 19 | 33 |
| 2015 4 | 10 | 17 | 27 |
| 2015 3 | 0 | 1 | 1 |
| 2015 2 | 1 | 0 | 1 |
| 2014 12 | 1 | 0 | 1 |
| 2014 10 | 1 | 0 | 1 |
| 2014 9 | 1 | 0 | 1 |
| 2014 7 | 1 | 0 | 1 |
| 2014 4 | 2 | 0 | 2 |
| 2014 3 | 36 | 1 | 37 |
| 2014 2 | 29 | 0 | 29 |
| 2014 1 | 28 | 0 | 28 |
| 2013 12 | 27 | 1 | 28 |
| 2013 11 | 31 | 2 | 33 |
| 2013 10 | 13 | 4 | 17 |
| 2013 9 | 26 | 0 | 26 |
| 2013 8 | 18 | 4 | 22 |
| 2013 7 | 16 | 0 | 16 |
| 2013 6 | 7 | 1 | 8 |
| 2013 3 | 152 | 0 | 152 |
Mostrar todo
